• Integrating sex and gender analysis into systematic reviews of drug treatments
• Integrating systematic review findings through risk stratification: the case of heart failure management
• Integrating systematic review meta-analysis, risk assessment and multi-criteria decision analysis: addressing the needs of policy and decision makers in zoonotic public health
• Integrating the Cochrane Review Methodology for Systematic Reviews and Meta-Analysis into an online learning course for medical students
• Integrating the evidence from an HIV/AIDS-related Symptom-Management Guideline into clinical practice: A preliminary study in China
• Integrating the findings of a qualitative evidence synthesis (QES) with the findings of a review of intervention effects
• Integration of Early Acupuncture in Bell's Palsy Treatment: real-world evidence from Korean nationwide insurance data
  
• Integration of Machine Learning in a living systematic review of baseline risks of Venous Thromboembolism complications in hospitalized patients with COVID-19
• Integration of meta-analysis and economic decision modelling for evaluating diagnostic tests
• Integration of multiple study designs in systematic reviews
• Integration of national practice guidelines in a comprehensive health examination form for primary care: a Philippine perspective
• Integration of primary health care: assessing the evidence.
• Integration of the JBI Evidence Implementation Program into a Doctor of Nursing Practice Program Curriculum: An Educational Initiative
  
• Integrative oncology in cancer care – implementation factors: mixed-methods systematic review
• Integrity in reporting research: what do Cochrane authors from LMICs think?
• Intelligent Related Citation Searching (IRIS) – development and validation of a new approach to identifying studies
• Intensity of a public health intervention in a systematic review: Assessing it
• Intensive education and facilitation: impact on practitioner understanding and use of evidence.
• Intensive insulin therapy in severe traumatic brain injury: a systematic review and meta-analysis of randomized controlled trials
• Intention to Participate in Basic Medical Insurance among Urban and Rural Residents in China: A Comprehensive Study Revealing Influencing Factors
• Inter-rater agreement and time to complete the new Cochrane Risk-of-Bias tool (RoB 2.0)
• Inter-rater reliability of a new instrument for assessing potential for bias in prognosis studies
• Inter-rater reliability of adapted Fresno test across multiple raters
• Inter-rater reliability of AMSTAR-2 in a review of systematic reviews about interventions to prevent adverse events in the intensive care unit
• Inter-rater reliability of AMSTAR: is it dependent on the pair of reviewers?
• Inter-rater reliability of the QUADAS-2 for assessing screening accuracy studies
• Inter-rater reliability of the Risk Of Bias Assessment Tool: for Non-Randomized Studies of Interventions (ACROBAT-NRSI)
• Inter-rater reliability, inter-consensus reliability and evaluator burden of ROBINS-E and ROBINS-I: a cross-sectional study
• Inter-reader variation
• Inter-reviewer agreement: an analysis of the degree to which agreement occurs when using tools for the appraisal, extraction and meta-synthesis of qualitative research findings
• Interactive 'Summary of findings' table (iSoF)
• Interactive health communication applications for patients with chronic disease
• Interactive Summary of Findings tables
• Interactive tools to teach the public to be critical consumers of information about health care: Whatás out there?
• Interactive website for communicating the results from a living systematic review and network meta-analysis for COVID-19
• Intercessory prayer: a systematic review at the limits of the randomized controlled trial
• Interest holder engagement in practice guideline development: a survey of methodological guidance by guideline-producing organizations
• Interferon-γ release assays vs. tuberculin skin test for the screening of latent tuberculosis infection: an overview of systematic reviews
• Interim guidance on the inclusion of Clinical Study Reports and other regulatory documents in Cochrane Reviews: a project summary
• Interim guidance on the inclusion of Clinical Study Reports and other regulatory documents in Cochrane Reviews: progress report
• Interim guideline development for public health emergencies: the Philippine Experience
• Internal validity of estimates of effectiveness from non-randomised studies
• International activity within Cochrane Review Groups
• International activity within Cochrane Review Groups
• International activity within Cochrane Review Groups
• International activity within Cochrane Review Groups
• International activity within Cochrane Review Groups
• International activity within Cochrane Review Groups
• International activity within Cochrane Review Groups
• International activity within collaborative review groups
• International activity within Collaborative Review Groups
• International Activity within Collaborative Review Groups
• International collaboration in Social Intervention Assessment – the establishment of INSIA
• International cooperation in the abstracts of the 20th Cochrane Colloquium
• International guidelines for perioperative blood-glucose management: Epidemiological studies and quality evaluation
• International Guidelines: Adapt to local clinical practice or not?
• International research collaboration and funding and the relevance of African randomised controlled trials
• International standards for Public Reporting of Clinical Trial Outcomes and Results (PROCTOR): a proposal to increase the quality of evidence produced by systematic reviews
• Internet-based data management tool for systematic reviews
• Interobserver reliability for application of tools for assessing quality and susceptibility to bias in observational studies
• Interpretation of patient-reported outcome measures: an inventory of over 3000 minimally important difference estimates and an assessment of their credibility
• Interpretation of PROS in Cochrane Reviews
• Interpretation of systematic review evidence: a tale of two nations
• Interpreting Cochrane systematic reviews: can we do without authors’ conclusions?
• Interpreting efficacy outcomes from open-label extension studies of anti-epileptic drugs
• Interpreting intergroup differences on low quality data of adverse events (AE) in primary clinical trials of non-drug interventions
• Interpreting pooled estimates in systematic reviews involving continuous variables
• Interpreting results of Cochrane Reviews and 'Summary of findings' tables
• Interpreting results of Cochrane Reviews and Summary of Findings Tables
• Interpreting results of Cochrane reviews, applying GRADE and creating ‘Summary of Findings’ tables
• Interpreting systematic review findings
• Interpreting systematic review findings (in Spanish)
• Interpreting the outcomes of stroke rehabilitation trials
• Interpreting the results of observational studies in the context of variation expected due to analytic flexibility
• Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study
• Interpreting your review: how to avoid Cochrane’s most common major errors
• Intervention bias: presence and impact in trials of socially-complex health care interventions
• Intervention Component Analysis (ICA): enhancing the “implementability” of review findings on complex interventions
• Intervention Now To Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT): multiple integrated review method exemplar
• Intervention of adolescent depressive disorder: An evidence and gap maps
• Interventions during study design and conduct to reduce the risk of bias in interventional studies: a scoping review
• Interventions for age-related macular degeneration: What is the quality of the evidence?
• Interventions for detection, prevention, and response to elder abuse and neglect: An evidence and gap map
• Interventions for improving condom use in people at risk for sexually transmitted diseases, including HIV
• Interventions for osteoporosis: a comparison of retrieval rates for RCTs using a broad labour-intensive search strategy, and Cochrane searching algorithms
• Interventions for pathological gambling: A systematic review
• Interventions for prevention and management of child abuse and neglect in low- and middle-income countries: an evidence and gap map
• Interventions for reducing violence against children: an Evidence and Gap Map in low- and middle-income countries
• Interventions for the control of childhood obesity in the South Asian region: a systematic review
• Interventions for Treating Hallux Valgus (Bunion)
• Interventions increasing accessibility of plain language summaries to non-scientific audiences in low-resourced contexts: Rationale and Design of the PLaSP study.
  
• Interventions to enhance patient adherence to medication prescriptions
• Interventions to improve neonatal and child survival
• Interventions to improve question formulation in professional practice and self-directed learning
• Interventions to improve the mental health of children and young people with long-term conditions: Can evidence of effectiveness and evidence of patient experience be mutually informing?
• Interventions to Optimize the Care Cascade for Migrants Living with Chronic Viral Hepatitis: A Mixed Methods Systematic Review
• Interventions to reduce or stop inappropriate drug prescription: An overview of systematic reviews
• Interventions to reduce the incidence of falling in the elderly
• Interventions with multiple components of risk assessment, education, reminders and feedback improve osteoporosis disease management: a systematic review and meta-analysis of RCTs
• Intravenous immunoglobulin for treating sepsis and septic
• Intravenous Immunoglobulin for Treating Sepsis and Septic Shock.
• Introducing a new GRADE evidence-to-decision framework for environmental health
• Introducing a revised risk of bias tool for randomized trials
• Introducing a revised tool for assessing risk of bias in randomized trials
• Introducing biomedical databases in China
• Introducing CiteSource: A new R package to explore source-level contributions to the stages of a systematic review
• Introducing Cochrane Global Mental Health: Improving the impact of Cochrane Mental Health in low- and middle-income countries
• Introducing cochrane reviews during the entry level physiotherapy curriculum—a preliminary report
• Introducing GRADEpro® and new features in RevMan 5
• Introducing INSPECT-SR: a tool for detecting problematic randomised controlled trials in health systematic reviews
• Introducing INSPECT-SR: a tool for detecting problematic randomized controlled trials in health systematic reviews
• Introducing KSR Evidence: developing a database of critically appraised systematic reviews in the field of pain relief
• Introducing LATITUDES, a library of assessment tools and instruments used to assess data validity in evidence syntheses
• Introducing LATITUDES: a library of assessment tools and instruments used to assess data validity in evidence syntheses
• Introducing new guidance for plain language summaries for diagnostic test accuracy (DTA) reviews
• Introducing the cochrane library in central and eastern Europe
• Introducing The Cochrane Nutrition & Public Health Thematic Group
• Introducing the Global Evidence Synthesis Initiative (GESI)
• Introducing the new Cochrane Handbook chapter on equity—methods for systematic reviews with a focus on equity
• Introducing the PRISMA 2020 adherence assessment form: a standardized approach for assessing completeness of reporting of systematic reviews
  
• Introducing the risk of bias tool for non-randomized studies
• Introducing theory into systematic reviews: a discussion workshop
• Introducing US family physicians to Cochrane reviews
• Introduction of ARRIVE guidelines and GSPC checklist to journals in the field of biomaterials: A survey research
• Introduction of high evidence knowledge into daily surgical practice in El Salvador
• Introduction to a new risk of bias tool for network meta-analysis (RoB NMA tool)
• Introduction to analysis and meta-analysis of interrupted time series studies
• Introduction to analysis and meta-analysis of interrupted time series studies with continuous outcomes
  
• Introduction to Cochrane Diagnostic Test Accuracy reviews (in Spanish)
• Introduction to Covidence - Cochrane's recommended online tool for review production
• Introduction to Covidence - Cochrane's recommended online tool for review production
• Introduction to Covidence - Cochrane's recommended online tool for review production
• Introduction to Covidence, Cochrane's recommended online tool for review production (for Spanish-speaking community)
• Introduction to diagnostic test accuracy (DTA) reviews
• Introduction to EPPI-Reviewer 4
• Introduction to evidence based practice in the Humanitarian Services of the Belgian Red Cross-Flanders: Experiences from a newly developed workshop
• Introduction to meta-analysis : meta-analysis of binary and continuous outcomes
• Introduction to meta-analysis 1: basic ideas for novices
• Introduction to meta-analysis 1: basic ideas for novices
• Introduction to meta-analysis 1: Basic ideas for novices
• Introduction to meta-analysis 1: basic ideas for novices
• Introduction to meta-analysis 1: basic ideas for novices
• Introduction to meta-analysis 1: meta-analysis of binary and continuous outcomes
• Introduction to meta-analysis 1: meta-analysis of binary and continuous outcomes
• Introduction to meta-analysis 2: dealing with heterogeneity
• Introduction to meta-analysis 2: dealing with heterogeneity
• Introduction to meta-analysis 2: meta-analysis of binary and continuous outcomes
• Introduction to meta-analysis 2: meta-analysis of binary and continuous outcomes
• Introduction to meta-analysis 2: Meta-analysis of binary and continuous outcomes
• Introduction to meta-analysis 2: meta-analysis of binary and continuous outcomes
• Introduction to meta-analysis 2: meta-analysis of binary and continuous outcomes
• Introduction to meta-analysis 3: dealing with heterogeneity
• Introduction to meta-analysis 3: dealing with heterogeneity
• Introduction to meta-analysis 3: dealing with heterogeneity
• Introduction to meta-analysis 3: dealing with heterogeneity
• Introduction to meta-analysis 3: Dealing with heterogeneity
• Introduction to meta-analysis 3: dealing with heterogeneity
• Introduction to meta-analysis 3: meta-analysis of time-to-event data
• Introduction to meta-analysis 4: including non-standard trials
• Introduction to meta-analysis 4: meta-analysis of time-to-event data
• Introduction to meta-analysis 4: meta-analysis of time-to-event data
• Introduction to meta-analysis 4: meta-analysis of time-to-event data
• Introduction to meta-analysis 5: including non-standard studies and non-standard data
• Introduction to meta-analysis 5: including non-standard studies and non-standard data
• Introduction to meta-analysis of continuous outcomes
• Introduction to meta-analysis using Stata
• Introduction to meta-analysis: basic ideas for novices – Part 1
• Introduction to meta-analysis: meta-analysis of binary and continuous outcomes – Part 2
• Introduction to meta-regression
• Introduction to network meta-analysis
• Introduction to plain language summaries for Cochrane Diagnostic Test Accuracy (DTA) Reviews
• Introduction to RevMan Web
• Introduction to RevMan Web
• Introduction to RevMan Web for Cochrane Editors and Trainers
• Introduction to ROBIS, a new tool to assess the risk of bias in a systematic review
• Introduction to ROBIS, a tool to assess risk of bias in a systematic review
• Introduction to ROBIS, a tool to assess the risk of bias in a systematic review
• Introduction to ROBIS, a tool to assess the risk of bias in a systematic review
• Introduction to Target Trial Emulation in Rehabilitation: A Systematic Approach to Emulate a Randomized Controlled Trial Using Observational Data
  
• Introduction to the Cochrane Register of Studies Online (CRSO)
• Introduction to the GRADE-CERQual approach for assessing confidence in evidence from reviews of qualitative research
  
• Introduction to the new guidance for plain-language summaries for Cochrane diagnostic test accuracy reviews
• Introduction to the RoB 2 tool for assessing risk of bias in a randomized trial
• Introduction to the ROBINS-I tool (Risk of Bias In Non-randomized Studies of Interventions)
• Introduction to the WISEST (Which Systematic Evidence Synthesis is best) Project: Developing an automated clinical decision-support algorithm to choose amongst systematic review(s) on the same topic
• Introduction to umbrella reviews
• Introductory/intermediate workshop for Cochrane Trials Search Co-ordinators
• Investigating and Dealing with Bias in Cochrane Systematic Reviews
• Investigating and dealing with bias in systematic reviews
• Investigating and dealing with bias in systematic reviews
• Investigating and dealing with bias in systematic reviews
• Investigating and dealing with bias in systematic reviews
• Investigating and improving the understanding of Cochrane Diagnostic Test Accuracy Reviews (DTARs)
• Investigating and improving the understanding of Cochrane diagnostic test accuracy reviews (DTARs)
• Investigating clinical heterogeneity in systematic reviews
• Investigating clinical heterogeneity in systematic reviews
• Investigating clinical heterogeneity insystematic reviews
• Investigating conflicting outcomes in pregnancy and childbirth Cochrane reviews: what to do when interventions are beneficial for one party only
• Investigating determinants of expertsá judgement on appropriateness for diagnostic tests when using the 'Grading of Recommendations Assessment, Development and Evaluation (GRADE)á method for presenting evidence
• Investigating Heterogeneity Across Studies - A Review of the Systematic Reviews in the Infectious Diseases Module of the Cochrane Library